Vikas V Dukhande

Years Active: 2019-2022
Publications (10 Years): 5

St. John's University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

St. John's University

United States

Assistant Professor :: Pharmaceutical Sciences

Publications

Anjali Yadav, Ali Alnakhli, Hari Priya Vemana, Shraddha Bhutkar, Aaron Muth, Vikas V Dukhande
Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma. Pharmaceutical research 39 (11) (2022)
Hari Priya Vemana, Vikas V Dukhande
Recent advances in the application of nanomedicine for the treatment of diabetes. Nanomedicine (London, England) 17 (2) (2022)
Yige Fu, Aishwarya Saraswat, Zenghui Wei, Manas Yogendra Agrawal, Vikas V Dukhande, Sandra E Reznik, Ketankumar Patel
Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma. Pharmaceutics 13 (7) (2021)
Hari Priya Vemana, Aishwarya Saraswat, Shraddha Bhutkar, Ketan Patel, Vikas V Dukhande
A novel gene therapy for neurodegenerative Lafora disease via EPM2A-loaded DLinDMA lipoplexes. Nanomedicine (London, England) 16 (13) (2021)
Yige Fu, Drishti Rathod, Ehab M Abo-Ali, Vikas V Dukhande, Ketankumar Patel
EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma. Pharmaceutics 11 (10) (2019)

Vikas V Dukhande.css-eqlu8i{font-size:small;padding-left:4px;}